![Adam Sinding Steensberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Sinding Steensberg
Vorstandsvorsitzender bei
ZEALAND PHARMA A/S
Vermögen: 6 Mio $ am 30.09.2026
Profil
Adam Sinding Steensberg currently works at Zealand Pharma A, as President & Chief Executive Officer from 2022 and The Danish Business Authority, as Chief Executive Officer from 2019.
Dr. Steensberg also formerly worked at Beta Bionics, Inc., as Director, Dansk Biotek, as Director, Cessatech A, as Independent Director, Novo Nordisk A, as Medical Director from 2006 to 2010, and Rigshospitalet, as Clinician.
Dr. Steensberg received his doctorate degree from the University of Copenhagen and Masters Business Admin degree in 2015 from International Institute for Management Development.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,2 % | 31.12.2025 | 143.559 ( 0,2 % ) | 6 Mio $ | 30.09.2026 |
Aktive Positionen von Adam Sinding Steensberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ZEALAND PHARMA A/S | Vorstandsvorsitzender | 30.03.2022 |
The Danish Business Authority
 The Danish Business Authority National AgencyGovernment Provides information on rules and registrations to foreign service providers | Vorstandsvorsitzender | 01.03.2019 |
Ehemalige bekannte Positionen von Adam Sinding Steensberg
| Unternehmen | Position | Ende |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.09.2010 |
| CESSATECH A/S | Direktor/Vorstandsmitglied | - |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Direktor/Vorstandsmitglied | - |
| BETA BIONICS, INC. | Direktor/Vorstandsmitglied | - |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Provides medical services | Corporate Officer/Principal | - |
Ausbildung von Adam Sinding Steensberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Rigshospitalet
Rigshospitalet Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
The Danish Business Authority
The Danish Business Authority National AgencyGovernment Provides information on rules and registrations to foreign service providers | Government |
Cessatech A/S
 Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
